Intarcia Therapeutics

Developer of drug therapies intended to deliver an improved therapeutic outcome while enhancing patients' quality of life. The company's proprietary subcutaneous delivery system comprises three unique technologies, including a stabilization technology that allows for proteins, peptides, antibody fragments, and other highly potent small molecules to be stabilized at or above human body temperatures, enabling patients to avail necessary treatment required for chronic serious disorders in the field of diabetes, obesity and autoimmune diseases.

New Enterprise Associates

🏥 Healthcare